These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22836613

  • 1. Tiotropium increases PPARγ and decreases CREB in cells isolated from induced sputum of COPD patients.
    Holownia A, Mroz RM, Skopinski T, Kolodziejczyk A, Chyczewska E, Braszko JJ.
    Adv Exp Med Biol; 2013; 756():9-14. PubMed ID: 22836613
    [Abstract] [Full Text] [Related]

  • 2. Altered histone deacetylase activity and iNOS expression in cells isolated from induced sputum of COPD patients treated with tiotropium.
    Holownia A, Mroz RM, Wielgat P, Skopinski T, Kolodziejczyk A, Sitko A, Chyczewska E, Braszko JJ.
    Adv Exp Med Biol; 2013; 788():1-6. PubMed ID: 23835951
    [Abstract] [Full Text] [Related]

  • 3. Siglec-8 in induced sputum of COPD patients.
    Mroz RM, Holownia A, Wielgat P, Sitko A, Skopinski T, Chyczewska E, Braszko JJ.
    Adv Exp Med Biol; 2013; 788():19-23. PubMed ID: 23835953
    [Abstract] [Full Text] [Related]

  • 4. Tiotropium increases cytosolic muscarinic M3 receptors and acetylated H3 histone proteins in induced sputum cells of COPD patients.
    Holownia A, Mroz RM, Skopinski T, Kielek A, Kolodziejczyk A, Chyczewska E, Braszko JJ.
    Eur J Med Res; 2010 Nov 04; 15 Suppl 2(Suppl 2):64-7. PubMed ID: 21147623
    [Abstract] [Full Text] [Related]

  • 5. Tregs and HLA-DR expression in sputum cells of COPD patients treated with tiotropium and formoterol.
    Holownia A, Wielgat P, Stasiak-Barmuta A, Kwolek A, Jakubow P, Szepiel P, Chyczewska E, Braszko JJ, Mroz RM.
    Adv Exp Med Biol; 2015 Nov 04; 839():7-12. PubMed ID: 25315616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
    Yasui H, Inui N, Furuhashi K, Nakamura Y, Uto T, Sato J, Yasuda K, Takehara Y, Suda T, Chida K.
    Pulm Pharmacol Ther; 2013 Jun 04; 26(3):336-41. PubMed ID: 23340058
    [Abstract] [Full Text] [Related]

  • 10. Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
    Mroz RM, Minarowski L, Chyczewska E.
    Adv Exp Med Biol; 2013 Jun 04; 756():23-8. PubMed ID: 22836615
    [Abstract] [Full Text] [Related]

  • 11. Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease.
    Holownia A, Mroz RM, Noparlik J, Chyczewska E, Braszko JJ.
    J Physiol Pharmacol; 2008 Dec 04; 59 Suppl 6():303-9. PubMed ID: 19218654
    [Abstract] [Full Text] [Related]

  • 12. A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease.
    Kern DM, Williams SA, Tunceli O, Wessman C, Zhou S, Pethick N, Elhefni H, Trudo F.
    Int J Chron Obstruct Pulmon Dis; 2014 Dec 04; 9():775-83. PubMed ID: 25071369
    [Abstract] [Full Text] [Related]

  • 13. Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function.
    Cazzola M, Tashkin DP.
    COPD; 2009 Oct 04; 6(5):404-15. PubMed ID: 19863370
    [Abstract] [Full Text] [Related]

  • 14. Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease.
    Fujimoto K, Kitaguchi Y, Kanda S, Urushihata K, Hanaoka M, Kubo K.
    Int J Chron Obstruct Pulmon Dis; 2011 Oct 04; 6():219-27. PubMed ID: 21660299
    [Abstract] [Full Text] [Related]

  • 15. Short term effect of a single dose of formoterol or tiotropium on the isolated nocturnal hypoxemia in stable COPD patients: a double blind randomized study.
    Sposato B, Franco C.
    Eur Rev Med Pharmacol Sci; 2008 Oct 04; 12(3):203-11. PubMed ID: 18700693
    [Abstract] [Full Text] [Related]

  • 16. β₂ long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD.
    Profita M, Bonanno A, Montalbano AM, Albano GD, Riccobono L, Siena L, Ferraro M, Casarosa P, Pieper MP, Gjomarkaj M.
    Biochim Biophys Acta; 2012 Jul 04; 1822(7):1079-89. PubMed ID: 22440430
    [Abstract] [Full Text] [Related]

  • 17. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S, Eberlein M, Eckhoff J, Schirren J.
    Eur J Cardiothorac Surg; 2011 Jun 04; 39(6):995-1000. PubMed ID: 20970351
    [Abstract] [Full Text] [Related]

  • 18. Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD.
    Tanabe N, Muro S, Oguma T, Sato S, Kiyokawa H, Takahashi T, Kudo M, Kinose D, Kubo T, Hoshino Y, Ogawa E, Hirai T, Mishima M.
    COPD; 2012 Aug 04; 9(4):401-8. PubMed ID: 22509949
    [Abstract] [Full Text] [Related]

  • 19. Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway.
    Costa L, Roth M, Miglino N, Keglowich L, Zhong J, Lardinois D, Tamm M, Borger P.
    Pulm Pharmacol Ther; 2014 Feb 04; 27(1):29-37. PubMed ID: 24269928
    [Abstract] [Full Text] [Related]

  • 20. Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease.
    Mroz RM, Holownia A, Chyczewska E, Drost EM, Braszko JJ, Noparlik J, Donaldson K, Macnee W.
    J Physiol Pharmacol; 2007 Nov 04; 58 Suppl 5(Pt 2):437-44. PubMed ID: 18204156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.